Cargando…

Expression and significance of transforming growth factor-β receptor type II and DPC4/Smad4 in non-small cell lung cancer

The aim of the present study was to investigate the expression levels of transforming growth factor-β (TGF-β) receptor type II (TβRII) and DPC4/Smad4 in the TGF-β signaling pathway and the importance of these expression levels in non-small cell lung cancer (NSCLC). The mRNA and protein expression le...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHEN, HONG, WANG, JING-WEI, LIU, LI-XIN, YAN, JI-DONG, REN, SHU-HUA, LI, YAN, LU, ZHENG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247285/ https://www.ncbi.nlm.nih.gov/pubmed/25452807 http://dx.doi.org/10.3892/etm.2014.2065

Ejemplares similares

Smad4 (DPC4)--a potent tumour suppressor?
por: Duff, E. K., et al.
Publicado: (1998)

DPC4 Expression in the Small Intestinal Adenocarcinomas
por: Lee, Sun Jae, et al.
Publicado: (2012)

Point mutations in the tumor suppressor Smad4/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-β signaling
por: Demagny, Hadrien, et al.
Publicado: (2015)

Zili Inhibits Transforming Growth Factor-β Signaling by Interacting with Smad4
por: Sun, Huaqin, et al.
Publicado: (2010)

The Loss of SMAD4/DPC4 Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer
por: Xu, Jin-Zhi, et al.
Publicado: (2019)

Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3ε
por: Liffers, Sven-T, et al.
Publicado: (2011)

Analysis of the DPC4 Gene in Gastric Carcinoma
por: Nishizuka, Satoshi, et al.
Publicado: (1997)

Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling
por: Demagny, Hadrien, et al.
Publicado: (2015)

The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study
por: Shin, Sang Hyun, et al.
Publicado: (2017)

Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?
por: Ungefroren, Hendrik, et al.
Publicado: (2023)

The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis
por: Yan, Chao, et al.
Publicado: (2015)

Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation
por: Li, Zhiqiang, et al.
Publicado: (2023)

Transforming growth factor-β and breast cancer: Transforming growth factor-β/SMAD signaling defects and cancer
por: Kretzschmar, Marcus
Publicado: (2000)

Integrating DPC++/oneAPI in the ATLAS software
por: Krasznahorkay, Attila
Publicado: (2023)

miR-148a downregulates the expression of transforming growth factor-β2 and SMAD2 in gastric cancer
por: ZHANG, WEI, et al.
Publicado: (2016)

Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/ transforming growth factor-β (TGF-β1)/Smad axis
por: Chen, Youquan, et al.
Publicado: (2021)

The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance
por: Ahmed, Sunjida, et al.
Publicado: (2017)

Differential Regulation of Smad3 and of the Type II Transforming Growth Factor-β Receptor in Mitosis: Implications for Signaling
por: Hirschhorn, Tal, et al.
Publicado: (2012)

The Effect of Hypoxia on the Stemness and Differentiation Capacity of PDLC and DPC
por: Zhou, Yinghong, et al.
Publicado: (2014)

Pokemon Inhibits Transforming Growth Factor β-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1
por: Chen, Ling, et al.
Publicado: (2019)

Tanshinone IIA alters the transforming growth factor-β1/Smads pathway in angiotensin II-treated rat hepatic stellate cells
por: Wei, Guo-wei, et al.
Publicado: (2020)

The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms
por: Guo, Zhu-Ling, et al.
Publicado: (2016)

Transforming Growth Factor Beta Promotes Inflammation and Tumorigenesis in Smad4‐Deficient Intestinal Epithelium in a YAP‐Dependent Manner
por: Liu, Liansheng, et al.
Publicado: (2023)

Tumor Suppressor Bromodomain-containing Protein 7 Cooperates with Smads to Promote Transforming Growth Factor-β Responses
por: Liu, Ting, et al.
Publicado: (2016)

Transforming Growth Factor β1/Smad4 Signaling Affects Osteoclast Differentiation via Regulation of miR-155 Expression
por: Zhao, Hongying, et al.
Publicado: (2017)

Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling
por: Ji, Xingli, et al.
Publicado: (2018)

microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
por: Qiao, Pengfei, et al.
Publicado: (2015)

Scutellarin-induced A549 cell apoptosis depends on activation of the transforming growth factor-β1/smad2/ROS/caspase-3 pathway
por: Zhang, Guang-Yan, et al.
Publicado: (2021)

Astragaloside IV controls collagen reduction in photoaging skin by improving transforming growth factor-β/Smad signaling suppression and inhibiting matrix metalloproteinase-1
por: CHEN, BIN, et al.
Publicado: (2015)

Role of Transforming Growth Factor-β1 and Smads Signaling Pathway in Intrauterine Adhesion
por: Salma, Umme, et al.
Publicado: (2016)

Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
por: Troncone, Edoardo, et al.
Publicado: (2018)

Role of Hypothalamic Transforming Growth Factor-β (TGF-β)/Smad Signaling in Feeding Regulation in Chickens
por: Saneyasu, Takaoki, et al.
Publicado: (2022)

Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor-β/Smad pathway in rats
por: HUANG, WEIJUAN, et al.
Publicado: (2015)

SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4
por: Bertrand-Chapel, Adrien, et al.
Publicado: (2022)

The Development of iDPC-STEM and Its Application in Electron Beam Sensitive Materials
por: Wang, Hongyi, et al.
Publicado: (2022)

Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines
por: Bai, Yihua, et al.
Publicado: (2019)

The effect of transforming growth factor-β1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-β/Smad pathway
por: Xiao, Jian, et al.
Publicado: (2010)

Smad4-mediated TGF-β signaling in tumorigenesis
por: Yang, Guan, et al.
Publicado: (2010)

The role of TGF-β/SMAD4 signaling in cancer
por: Zhao, Ming, et al.
Publicado: (2018)

SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors
por: Hofving, Tobias, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_epm91pso0uqgjjdrdn9qql90s5